Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Nanotherapeutic intervention
 CHO & downstream Filters
 Hemocraft
Nov 2017 e-Newsletter Archives    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
 Etihad
News
Fresenius Kabi to Expand Pharmaceutical...
Orig3n™Acquires Interleukin Genetics
FDA Renews and Expands its Portfolio of Simcyp...
 
Press Releases
FDA Grants Breakthrough Therapy Designation and...
Innate Pharma provides an update on lirilumab
Orchard Therapeutics Announces Extension of its Collaboration with...
 
Events
28 -29 Nov 2017
Partnerships in Clinical Trials Europe
06 -10 Dec 2017
Dubai ID week
12 -14 Dec 2017
Gut-Brain Axis Summit
Articles
  Nanotherapeutic Intervention in Cancer Disease
Habban Akhter , Assistant Professor, Faculty of Pharmacy, DIT University, Dehradun, India
Cancer has been spreading worldwide, consequently high number of deaths reported. The therapeutic intervention involves surgical removal, radiation therapy and chemotherapy. The conventional technique in the drug regimen lack targeting potential and affecting normal...
Techno Trends
 Merck Announces First-of-its Kind Filters for CHO & Downstream...
 Pfizer Launches First-of-its Kind Innovative Technologies for Hemophilia...
 Breakthrough Therapy Designation to Adcetris for Frontline Advanced...
Emirates Skycargo
Projects
 Natco Pharma Plans to Expand its API facility in Tamil Nadu with...
  Sterling Invests $8 Million to Expand its Million, Micronisation and...
  Merck Invests $41 Million in Its Italian Biotech Manufacturing Site of...
FPS
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555